The role of erythrocytes in the deperoxidative processes in people on hemodialysis

被引:4
作者
Biasioli, S [1 ]
Schiavon, R [1 ]
DeFanti, E [1 ]
Cavalcanti, G [1 ]
Giavarina, D [1 ]
机构
[1] LEGNAGO HOSP,CLIN CHEM LAB,I-37045 LEGNANO,ITALY
关键词
D O I
10.1097/00002480-199609000-00120
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The defenses against the production of free radicals and reactive oxygen species (ROS) are to be found in plasma (ascorbate, urate, alpha tocopherol) and in erythrocytes (superoxide dismutase or SOD; catalase or CAT; glutathione peroxidase or GPx). In chronic renal failure, an increased lipid peroxidation and a reduced antioxidant activity seem to be present, but previous reports are conflicting. To clarify the peroxidative status and the defense mechanisms taking place in patients on dialysis, in 30 patients on dialysis (15 men, 15 women) and in 20 control subjects (10 men, 10 women), the following parameters were measured: plasma 4-hydroxinonenal (4-HNE) and erythrocyte reduced glutathione (GSH), SOD, GPx, and glucose-6-phosphate dehydrogenase (G-6-PD). Patients on dialysis, in comparison with control subjects, had 1) increased levels of 4-HNE (p < 0.001); 2) a significant increase in erythrocyte-GSH (p < 0.05); and 3) significant decreases in erythrocyte-SOD (p < 0.001), erythrocyte-G-C-PD (p < 0.005), and the erythrocyte-SOD/GPx ratio (p < 0.001). The dialysis procedure induced a certain reduction in plasma 4-HNE, an increase in erythrocyte-SOD activity, and an important consumption of erythrocyte-GSH, while the erythrocyte-SOD/GPx ratio changed. The current study supports the view that 1) erythrocytes act as small detoxifying packets; 2) in chronic renal failure, the antioxidant system is largely inadequate; and 3) in patients on dialysis, the antioxidant mechanism of erythrocytes in scavenging ROS is effectively exerted during dialysis but remains largely inadequate, as signs of lipid peroxidation persist with time.
引用
收藏
页码:M890 / M894
页数:5
相关论文
共 54 条
[1]  
AMSTAD P, 1994, J BIOL CHEM, V269, P1606
[2]   ANTIOXIDANT ENZYMES AND LIPOPEROXIDE IN BLOOD IN UREMIC CHILDREN AND ADOLESCENTS [J].
ASAYAMA, K ;
SHIKI, Y ;
ITO, H ;
HASEGAWA, O ;
MIYAO, A ;
HAYASHIBE, H ;
DOBASHI, K ;
KATO, K .
FREE RADICAL BIOLOGY AND MEDICINE, 1990, 9 (02) :105-109
[3]  
Beutler E, 1975, RED CELL METABOLISM, V2nd, P71
[4]  
BEUTLER E, 1989, GLUTATHIONE CHEM BIO, P291
[5]   INACTIVATION OF GLUTATHIONE-PEROXIDASE BY SUPEROXIDE RADICAL [J].
BLUM, J ;
FRIDOVICH, I .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1985, 240 (02) :500-508
[6]   DETERMINATION OF ERYTHROCYTE SUPEROXIDE-DISMUTASE, CATALASE, GLUCOSE-6-PHOSPHATE-DEHYDROGENASE, REDUCED GLUTATHIONE AND MALONYLDIALDEHYDE IN UREMIA [J].
CHAUHAN, DP ;
GUPTA, PH ;
NAMPOOTHIRI, MRN ;
SINGHAL, PC ;
CHUGH, KS ;
NAIR, CR .
CLINICA CHIMICA ACTA, 1982, 123 (1-2) :153-159
[7]  
CORNELIS R, 1979, MINER ELECTROL METAB, V2, P88
[8]   INCREASED LIPID-PEROXIDATION IN PATIENTS ON MAINTENANCE HEMODIALYSIS [J].
DASGUPTA, A ;
HUSSAIN, S ;
AHMAD, S .
NEPHRON, 1992, 60 (01) :56-59
[9]  
DEHAAN JB, 1995, BIOCHEM MOL BIOL INT, V35, P1281
[10]   EVALUATION OF RED-BLOOD-CELL LIPOPEROXIDATION IN HEMODIALYZED PATIENTS DURING ERYTHROPOIETIN THERAPY SUPPLEMENTED OR NOT WITH IRON [J].
DELMASBEAUVIEUX, MC ;
COMBE, C ;
PEUCHANT, E ;
CARBONNEAU, MA ;
DUBOURG, L ;
DEPRECIGOUT, V ;
APARICIO, M ;
CLERC, M .
NEPHRON, 1995, 69 (04) :404-410